Active Substance: Entecavir.
Overview
Welcome to Dwaey, specifically on ARVIDA 0.5mg page.
This medicine contains an important and useful components, as it consists of
Entecaviris available in the market in concentration
Entecavir
Lactic acidosis: Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases have been reported with the use of nucleoside analogues alone or in combination with antiretrovirals.Exacerbations of hepatitis after discontinuation of treatment: Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy, including Entecavir. Lactation: excretion in milk unknown/not recommended
Chronic hepatitis B
Entecavir is contraindicated in patients with previously demonstrated hypersensitivity to Entecavir or any component of the product.
1-10% Fatigue (1-3%),Headache (2-4%),Dizziness,Nausea <1% Diarrhea,Dyspepsia,Vomiting,Somnolence,Insomnia
3
Selective HBV DNA polymerase inhibitor; inhibition blocks reverse transcriptase activity, which in turn reduces viral DNA synthesis
Drugs that reduce renal function or compete for active tubular secretion may increase serum conc of either entecavir or co-administered drug.
Information not available